CORESTEM Inc. is a Korea-based bio pharmaceutical company engaged in researching, developing and manufacturing stem cell medicines. The Company's product includes stem cell medicines under the brand NEURONATA-R for the treatment of Lou Gehrig's disease, and cosmetics such as mask pack for moisturizing and calming skin and repairing damaged skin. And the Company along with its subsidiary CHEMON INC. is conducting nonclinical and clinical trials for stem cell medicines for the treatment of anaerobic brain damage, multiple system atrophy, systemic lupus erythematosus, arthritis and cartilage loss. In addition, The Company's subsidiary CHEMON INC. provides nonclinical trials for other pharmaceutical companies.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.